Becton, Dickinson and Company (BDX)
| Market Cap | 69.87B |
| Revenue (ttm) | 18.86B |
| Net Income (ttm) | 1.64B |
| Shares Out | 290.56M |
| EPS (ttm) | 5.61 |
| PE Ratio | 42.82 |
| Forward PE | 18.52 |
| Dividend | $3.24 |
| Dividend Yield | 1.35% |
| Trading Day | June 22 |
| Last Price | $240.32 |
| Previous Close | $240.83 |
| Change ($) | -0.51 |
| Change (%) | -0.21% |
| Day's Open | 241.12 |
| Day's Range | 238.94 - 241.25 |
| Day's Volume | 1,429,997 |
| 52-Week Range | 217.25 - 282.05 |
FRANKLIN LAKES, N.J., June 22, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its 2020 Sustainability Report, highlighting...
Here we look at three stocks, VEEV, HSIC and BDX, that investors can keep a watch on the back of their robust cybersecurity measures.
BD (BDX) to provide rapid antigen testing for COVID-19 at the U.S. Olympic Team Trials and other competitive swimming events on behalf of USA Swimming.
FRANKLIN LAKES, N.J., June 11, 2021 /PRNewswire/ -- USA Swimming, the national governing body for the sport of swimming in the United States, and BD (Becton, Dickinson and Company) (NYSE: BDX), a leadin...
BD (BDX) receives 2 billion pandemic orders for needles and syringes to support global COVID-19 vaccination efforts.
Investors looking for the highest-quality dividend growth stocks to buy and hold for the long term should consider the Dividend Aristocrats, note Ben Reynolds and Bob Ciura, editors at Sure Dividend and...
FRANKLIN LAKES, N.J., June 8, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received pandemic orders for n...
BD's (BDX) authorization as a CNA is expected to allow it to provide customers with timely information about vulnerabilities in BD products available globally.
FRANKLIN LAKES, N.J., June 2, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has become the first medical techn...
BD's (BDX) UCA leverages AI to revolutionize the way microbiology labs conduct urine culture analysis.
Matrix Asset's David Katz makes the case for Amgen, Viacom and Verizon
David Katz, Matrix Asset Advisors chief investment officer, and Jerry Castellini, CastleArk Management chief investment officer, join 'The Exchange' to discuss their market outlook as the economy reopen...
FRANKLIN LAKES, N.J., May 26, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following upco...
FRANKLIN LAKES, N.J., May 26, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. launch of a Urine Culture Applica...
FRANKLIN LAKES, N.J., May 25, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the availability of BD Surgiphor™ Sterile ...
BD's (BDX) industry-first CE marked self-collection claim for HPV screening enables greater access to testing for women.
Becton Dickinson and Co (NYSE: BDX) will build a €165 million ($200 million) high-tech manufacturing facility in Zaragoza, Spain, that will create up to 600 jobs by 2030. BD plans to begin constructing ...
MADRID, May 18, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will build a €165 million ($200 million USD) high-tech manufacturing fac...
FRANKLIN LAKES, N.J., May 13, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the industry's first self-collection claim...
, a leading global medical technology company, announced that its Board of Directors have unanimously authorized management to go ahead with a plan to spinoff the Diabetes Care business into an independ...
Becton, Dickinson & Co. ( BDX , Financial) delivered another strong top and bottom-line beat when it reported earnings results last week.
Syringe maker Becton, Dickinson CEO on the Covid supply chain
CNBC's "Power Lunch" team discusses syringe supply and the Covid supply chain with Becton, Dickinson CEO Tom Polen.
Each of Becton Dickinson's (BDX) core units witnesses strong revenue growth in the fiscal second quarter.
While reporting financial results for the second fiscal quarter of the year, during which revenues grew more than 15% to $4.9 billion, Becton Dickinson and Co (NYSE: BDX) also laid out its plans to spin...
Becton Dickinson (BDX) delivered earnings and revenue surprises of 4.93% and 1.47%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Becton Dickinson and Co (NYSE: BDX) reported Q2 revenues of $4.91 billion, an increase of 15.4% Y/Y, slightly better than the consensus of $4.89 billion. The growth was driven by the contribution of its...
FRANKLIN LAKES, N.J., May 6, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its board of directors has unanimously auth...
FRANKLIN LAKES, N.J., May 6, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.9 billion for the s...
Becton, Dickinson (BDX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
BD's (BDX) second-quarter fiscal 2021 results are likely to reflect strong year-over-year growth in revenues from assays in its Life Sciences segment.
FRANKLIN LAKES, N.J., April 29, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following up...
Becton Dickinson (BDX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FRANKLIN LAKES, N.J., April 29, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that enrollment has begun and the first ...
FRANKLIN LAKES, N.J., April 28, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Elizabeth McCombs as ...
FRANKLIN LAKES, N.J., April 27, 2021 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.83 per common share, payable on June...
ZARAGOZA, Spain and FRANKLIN LAKES, N.J., April 27, 2021 /PRNewswire/ -- CerTest Biotec, along with BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today ann...
Healthcare stocks have some excellent dividend stocks among their ranks, and these three names are among the most reliable to buy. The post 3 Top Blue-Chip Healthcare Stocks With Healthy Dividends appea...
FRANKLIN LAKES, N.J., April 26, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has submitted a 510(k) premarket noti...
FRANKLIN LAKES, N.J., April 23, 2021 /PRNewswire/ -- USA Track & Field (USATF) and BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, have partnered to provide ...
Less COVID-19 testing means less revenue for some companies.
FRANKLIN LAKES, N.J., April 22, 2021 /PRNewswire/ -- In recognition of Earth Day, BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, reinforces its commitment t...
FRANKLIN LAKES, N.J., April 20, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company), a leading global medical technology company, is voluntarily recalling specified lots of the ChloraPrep™ Hi-Lite O...
FRANKLIN LAKES, N.J., April 20, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a $1 million commitment over five years ...
Becton Dickinson (BDX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Shares of DEH stock are climbing on Thursday after news of D8 Holdings SPAC merger with Bill Gates-backed Vicarious Surgical emerged. The post DEH Stock: 5 Things to Know About D8 Holdings and the Vicar...
FRANKLIN LAKES, N.J., April 14, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received 510(k) clearance from th...
FRANKLIN LAKES, N.J., April 13, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its BD MAX™ Molecular Multi-Drug Re...
Let's take a look at the three women healthcare MedTech stocks performing well lately.
With so much uncertainty clouding the market, you'll want a healthy serving of these blue-chip stocks in your portfolio. The post 7 Top Blue-Chip Stocks for the Rest of 2021 appeared first on InvestorPl...
BD's (BDX) $65-million investment in constructing an advanced facility will become integral to the U.S. medical device supply chain.
About BDX
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; in... [Read more...]
| Industry Medical Instruments & Supplies | IPO Date Apr 23, 1962 |
| CEO Thomas Polen | Employees 70,000 |
| Stock Exchange NYSE | Ticker Symbol BDX |
Financial Performance
In 2020, BDX's revenue was $17.12 billion, a decrease of -1.00% compared to the previous year's $17.29 billion. Earnings were $874.00 million, a decrease of -29.17%.
Analyst Forecasts
According to 18 analysts, the average rating for BDX stock is "Buy." The 12-month stock price forecast is 278.40, which is an increase of 15.85% from the latest price.